Cashu
Analysts Split on Apellis Pharmaceuticals' Future Amid Strategic Developments and Market Challenges
24 days ago
Stocks
Health Care
apls
Apellis Pharmaceuticals
NASDAQ: APLS
+23.14 (+135.40%)
40.23
USD
At close at Mar 31, 20:42 UTC
Latest Apellis Pharmaceuticals News
cnbc.com
Stocks making the biggest moves midday: Snap, McCormick & Co, Rocket Lab, Apellis, Marvell & more
about 5 hours ago
prnewswire.com
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
about 6 hours ago
benzinga.com
Assessing Apellis Pharmaceuticals: Insights From 11 Financial Analysts
26 days ago
benzinga.com
Apellis Pharmaceuticals Earnings Report: Q4 Overview
about 1 month ago
benzinga.com
Earnings Scheduled For February 24, 2026
about 1 month ago
benzinga.com
A Glimpse of Apellis Pharmaceuticals's Earnings Potential
about 1 month ago
benzinga.com
S&P 500 Hits New Record Highs, Alphabet Dethrones Apple: What's Moving Markets Wednesday?
3 months ago
benzinga.com
This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power
5 months ago
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
5 months ago
benzinga.com
Earnings Scheduled For October 30, 2025
5 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.